Navigation Links
New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
Date:5/16/2008

- Five Oral Presentations at ASCO Annual Meeting Will Further Demonstrate the Strength of VELCADE Combinations in Front-line Multiple Myeloma -

CAMBRIDGE, Mass., May 16 /PRNewswire/ -- Millennium Pharmaceuticals, The Takeda Oncology Company, today announced that new data from VELCADE clinical studies are scheduled to be featured at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 30 - June 3, 2008. The data will highlight the significant efficacy of multiple VELCADE based therapies in patients with newly diagnosed multiple myeloma (MM).

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The Company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) in December 2007 for the use of VELCADE to treat patients with newly diagnosed MM. The filing is based on data from the landmark Phase III VISTA trial. The FDA granted the sNDA priority review and a decision is expected by June 20, 2008. VELCADE is currently the market leader in relapsed multiple myeloma and the only drug approved for the treatment of relapsed mantle cell lymphoma.

"VELCADE based therapies continue to demonstrate unprecedented complete remission rates and survival benefits for patients with newly diagnosed multiple myeloma," said Nancy Simonian, M.D., Chief Medical Officer, Millennium. "Data to be presented at ASCO are expected to support that deep and durable complete remissions are an important indicator for long-term patient outcomes. The continued strength of clinical trial data, combined with the pending FDA approval, will further solidify VELCADE as a key component of the standard of care for this disease."

Newly Diagnosed Multiple Myeloma

Data to be featured at ASCO include the use of VELCADE in both newly diagnosed transplant and non-transplant MM patients. The da
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
2. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
3. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
4. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
5. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
6. Data Presented at AAN Support Potential for Adjunctive use of Intravenous Lacosamide as Short-Term Replacement for Oral Treatment in Partial Epilepsy
7. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
8. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
9. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
10. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
11. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... YORK , Dec. 18, 2014 Somewhere ... addressing hearing health was forgotten. But Audicus , ... to hear better this new year. Hearing ... facing the aging population, though it is often unaddressed. ... in four has a hearing aid, mainly due to ...
(Date:12/19/2014)... REDWOOD CITY, Calif., Dec. 18, 2014 ... on the development of medical diagnostics based on ... of gas flow, today announced financial results for ... 30, 2014. "Following the completion of ... well positioned to maximize the recently initiated CoSense® ...
(Date:12/19/2014)... , Dec. 18, 2014   Aratana ... a biopharmaceutical company focused on the licensing, development ... today announced positive results from its pivotal field ... for treating pain in dogs with osteoarthritis.  In ... pain assessment scores that were statistically significant compared ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... Nov. 2, 2010 Cambrex Corporation (NYSE: CBM ... Zenara Pharma, a Hyderabad, India based pharmaceutical company focused on ... Highlights To be named ... global suppliers to the large and growing Nicotine Replacement Therapy ...
... Charleston Laboratories, Inc., an emerging specialty pharmaceutical ... (OINV) in opioid pharmaceuticals, announced today that it ... government under the Qualifying Therapeutic Discovery Project (QTDP) ... award to advance the development of its lead ...
Cached Medicine Technology:Cambrex Acquires Stake in Zenara Pharma 2Cambrex Acquires Stake in Zenara Pharma 3Cambrex Acquires Stake in Zenara Pharma 4Charleston Laboratories, Inc. Awarded a Qualifying Therapeutic Discovery Project (QTDP) Grant Under the U.S. Patient Protection and Affordable Care Act of 2010 2
(Date:12/20/2014)... 2014 Weddingshe.com has recently announced its ... site-wide promotion of special occasion dresses for the coming ... of special occasion dresses for global women. Now, all ... discounts, up to 80% off. Among the new items, ... Sweet 16 Dress) is very popular. What’s more, Weddingshe.com ...
(Date:12/20/2014)... DePuy Pinnacle hip lawsuits ( ... the artificial hip system was defectively designed continue ... Bernstein Liebhard LLP reports. According to an Order ... on December 2nd, counsel in 10 DePuy Pinnacle ... on November 19, 2014, with depositions to conclude ...
(Date:12/20/2014)... 2014 Recently, VogueQueen.com, a leading wedding ... Big Sale Online for 2015. Great discounts are ... and old consumers can get a discount, up to ... company’s website before January 30, 2015. , VogueQueen.com has ... launched a prom dress promotion. Many customers worldwide like ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 As ... move forward in U.S. courts, Bernstein Liebhard LLP ... suggests that children treated with the medication may ... to breast development and lactation. The study, which ... children and adolescents who began treatment with risperidone, ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special ... the coming Christmas. In the promotion, all buyers worldwide ... “We have something special for the women who are ... Moreover, our new collections of 2015 dresses have been ... at greatly discounted prices. Visit our website now before ...
Breaking Medicine News(10 mins):Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2
... ARLINGTON, Va., Jan. 8 A congressionally mandated "competitive ... slowest-rising cost in Medicare -- intended to reduce homecare ... and access to, care for patients and will drive ... columnist George F. Will,s recent column on healthcare ...
... WASHINGTON, Jan. 8 /PRNewswire-USNewswire/ -- Advocates ... sexual and reproductive health, has released an analysis ... U.S. lag far behind those in France, Germany, ... , The U.S. teen birth rate, for ...
... CHAPEL HILL, N.C., Jan. 8 Many companies ... to the unstable economic environment. More than,ever will ... to manage its,biggest asset -- customers. To excel ... must master many fronts: creating effective customer,listening posts, ...
... brings together public-private sector members to achieve ... The National eHealth Collaborative, formerly AHIC ... Washington, D.C. The National eHealth Collaborative ... creation of a secure, interoperable, nationwide health ...
... lead to extended life spans , , THURSDAY, Jan. 8 ... previously thought-to-be-separate pathways tied to aging, at least in ... is an orderly and deliberate genetic occurrence. , ... extend life and delay aging, the researchers said. , ...
... of skin cancer, researchers suggest , , THURSDAY, Jan. 8 ... cancer melanoma are increasing among men and women in ... , Whether the increase in melanoma signals an epidemic ... increasing among all Americans and cannot be due to ...
Cached Medicine News:Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 2Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 3Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 4Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 2Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 3Health News:Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4 2Health News:National eHealth Collaborative Launched 2Health News:National eHealth Collaborative Launched 3Health News:National eHealth Collaborative Launched 4Health News:National eHealth Collaborative Launched 5Health News:National eHealth Collaborative Launched 6Health News:Researchers Gain Insights Into Aging in Mice 2Health News:Melanoma Rates on the Rise in U.S. 2Health News:Melanoma Rates on the Rise in U.S. 3
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... Nerve Electrodes provide direct cranial nerve ... patented circumferential design provides sensitive contact ... stable real-time recordings. This unique approach ... the removal of acoustic neuromas, microvascular ...
... Ad-Techs Model CMU Cortical Mapping Unit ... of recording EEGs from exposed cortex during ... each electrode plate can be positioned independently ... clamp provides two alternative mounting locations and ...
An ambulatory recorder can help the patient be more comfortable and at ease as well as increasing an EEG laboratory's recording capacity....
Medicine Products: